Alzai Health Income Statement

Financials in millions CAD. Fiscal year is May - April.

Millions CAD. Fiscal year is May - Apr.

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025
Revenue	0.07	0.03	-
Revenue Growth	-	-	-
Cost of Revenue	0.55	0.41	0.04
Gross Profit	-0.48	-0.39	-0.04
Selling, General & Admin	1.59	1.55	1.17
Research & Development	1.25	1.13	0.26
Operating Expenses	3.52	3.24	1.44
Operating Income	-4	-3.62	-1.48
Interest Expense	-0.09	-0.06	-
Interest & Investment Income	0	0	0
Currency Exchange Gain (Loss)	-0.03	0.02	-0
Other Non Operating Income (Expenses)	-0	-0	-0.03
EBT Excluding Unusual Items	-4.12	-3.67	-1.5
Other Unusual Items	-0.01	-0.01	-
Pretax Income	-4.13	-3.68	-1.5
Net Income	-4.13	-3.68	-1.5
Net Income to Common	-4.13	-3.68	-1.5
Net Income Growth	-	-	-
Shares Outstanding (Basic)	54	51	32
Shares Outstanding (Diluted)	54	51	32
Shares Change	-	60.63%	-
EPS (Basic)	-0.08	-0.07	-0.05
EPS (Diluted)	-0.08	-0.07	-0.05
EPS Growth	-	-	-

Additional Metrics

Fiscal Year	TTM	FY 2026	FY 2025
Period Ending	Jul '26 Jul 31, 2026	Apr '26 Apr 30, 2026	Apr '25 Apr 30, 2025
Free Cash Flow	-3.75	-2.61	-1.14
Free Cash Flow Per Share	-0.07	-0.05	-0.04
Operating Margin	-5783.60%	-13405.82%	-
Profit Margin	-5981.44%	-13593.12%	-
Free Cash Flow Margin	-5421.93%	-9653.91%	-
EBITDA	-4	-3.62	-
D&A For EBITDA	-0	0	-
EBIT	-4	-3.62	-1.48